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Abstract 
BMAA is a potential neurotoxin, related to neurodegenerative diseases (ALS/PDC 
and Alzheimer). Hypothesis that BMAA can be accumulated by some marine 
invertebrates has been formulated. Since it was recently discovered that in Portuguese 
estuaries various strains of cyanobacteria produce BMAA, the aim of this study was to 
obtain data about the potential transfer of the neurotoxin from cyanobacteria to marine 
invertebrates, which are part of the human trophic chain.  
For that Mytilus galloprovincialis (mussel) and Gibbula umbilicalis (sea snail) were 
used for a bioaccumulation experiment. They are common organisms in Portuguese 
coastal ecosystems and present different ways of feeding. The collection of these species 
was done in a beach at Matosinhos, Portugal. These mussels and sea snails were, then, 
placed in aerated 20 L aquariums for acclimation during one week. Mussels were exposed 
to different concentrations of BMAA standard for 24 and 48 h. The results showed that 
mussels were able to accumulate BMAA, and the uptake rate was higher in the first 24 h. 
Afterwards, mussels and sea snails were fed with cyanobacteria strains and collected 
at different times of exposure, ranging from 4 to 15 days of feeding and 10 days of 
depuration. The samples were acid digested and enzymatically digested (pepsin, trypsin 
and chymotrypsin) and analyzed by LC-MS/MS, with or without derivatization. The 
maximum concentration of BMAA in mussels was observed after 10 days of feeding with 
41,92 ± 15,13 µg/g measured after acid digestion, meaning that there was 
bioaccumulation. After 10 days of depuration, BMAA was still detected in a concentration 
of 15,29 ± 0,66 µg/g. Samples digested with enzymes showed lower BMAA 
concentrations, as expected, but followed the same pattern of accumulation during the 
feeding period, followed by a decrease in BMAA concentration during the depuration 
period. The fact that digestive enzymes allow the release of BMAA, propose a possible 
way of transfer of BMAA through food chain. Regarding the sea snails, no BMAA could be 
measured in this organism. 
Metabolic effects of BMAA were studied in cells of gills and hepatopancreas isolated 
from mussels fed with cyanobacteria. Inhibition of metabolic activity was observed after 20 
h of cell growth, where the cells presented a lower growth rate for longer periods of 
feeding. Part of this inhibition of metabolic activity was considered to be due to BMAA. 
iv 
With this work it was possible to see that BMAA bioaccumulation can occur in some 
marine invertebrates and has the potential to be transferred through the trophic chain. 
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Resumo 
A BMAA é uma potencial neurotoxina, relacionada com doenças neurodegenerativas 
(esclerose lateral amiotrófica/coocorrência com Parkinson e demência e Alzheimer). Tem 
sido sugerido que a BMAA pode ser acumulada por alguns invertebrados marinhos. Foi 
recentemente descoberto que várias estirpes de cianobactérias de estuários Portugueses 
são capazes de produzir BMAA. 
O objetivo deste estudo foi obter dados relativos à potencial transferência da 
neurotoxina de cianobactérias para invertebrados marinhos, que fazem parte da cadeia 
trófica humana. 
Para tal, Mytilus galloprovincialis (mexilhão) e Gibbula umbilicalis (caracóis do mar) 
foram utilizados para uma experiência de bioacumulação. Estes organismos são comuns 
nos ecossistemas costeiros portugueses e apresentam mecanismos de alimentação 
diferentes. A recolha destes organismos foi realizada na praia de Matosinhos, em 
Portugal. Depois, estes mexilhões e caracóis do mar foram colocados em aquários de 20 
L com arejamento, para aclimatação, durante uma semana. Os mexilhões foram expostos 
a diferentes concentrações de padrão de BMAA durante 24 e 48 h. Os resultados 
mostraram que os mexilhões eram capazes de acumular BMAA e que a taxa de 
acumulação foi maior nas primeiras 24 h. 
De seguida, mexilhões e caracóis do mar foram alimentados com estirpes de 
cianobactérias e recolhidos a diferentes tempos de exposição, sendo que variaram entre 
um máximo de 15 dias de alimentação e 10 dias de depuração. As amostras foram 
digeridas com ácido e digeridas com enzimas digestivas (pepsina, tripsina e 
quimotripsina) e analisadas por LC-MS/MS, com ou sem derivatização. A concentração 
máxima de BMAA em mexilhões foi observada ao fim de 10 dias de alimentação com 
41,92 ± 15,13 µg/g, medidos após a digestão ácida, evidenciando a existência de 
bioacumulação. Após 10 dias de depuração, ainda foi possível detectar BMAA numa 
concentração de 15,29 ± 0,66 µg/g. As amostras digeridas com enzimas mostraram 
concentrações mais baixas de BMAA, como era esperado, mas seguindo o mesmo 
padrão de acumulação durante o período de alimentação, seguido pela diminuição da 
concentração de BMAA durante o período de depuração. O facto de as enzimas 
digestivas permitirem a libertação de BMAA, sugere que existe a possibilidade de 
transferência desta neurotoxina através da cadeia alimentar. Relativamente aos caracóis 
do mar, não foi possível detectar BMAA nestes organismos. 
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Os efeitos metabólicos da BMAA em células das brânquias e do hepatopâncreas 
isoladas dos mexilhões alimentados com cianobactérias, foram estudados. Foi observada 
inibição da atividade metabólica após 20 h de crescimento celular, sendo que as células 
apresentaram uma taxa de crescimento mais baixa nos períodos mais longos de 
alimentação. Parte desta inibição considerou-se devida à BMAA. 
Com este trabalho, foi possível observar que a BMAA pode ser acumulada em 
alguns invertebrados marinhos e pode ser transferida através da cadeia trófica. 
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1. Introduction 
1.1. Cyanobacteria 
Cyanobacteria, also known as blue-green algae, can be distinguished from all other 
prokaryotes by their ability to carry out oxygen-producing photosynthesis (Paul, 2008). 
They can grow in any type of water (freshwater, brackish and marine) (Bláha et al., 2009). 
The cyanobacteria provide an extraordinarily wide-ranging contribution to human affairs in 
everyday life and are of economic importance (Bartram et al., 1999). They are important 
primary producers and their general nutritive value is high (Bartram et al., 1999). Due to 
the fact that they include nitrogen-fixing species, they contribute to soil and water fertility 
(Bartram et al., 1999). They are, also, used in alimentation and food production (Bartram 
et al., 1999). However, abundant growth of cyanobacteria in water reservoirs creates 
severe practical problems for water supplies (Bartram et al., 1999). There are two main 
factors that contribute for the increase of occurrence of these blooms:  anthropogenic 
eutrophication, with nutrient overenrichment of waters by urban, agricultural, and industrial 
development; and climate change, a potent catalyst for the expansion of these blooms 
(elevation of temperature, increased atmospheric concentrations of carbon dioxide, 
elevated UV fluxes, and elevated pH values) (Paerl and Huisman, 2008; Bláha et al., 
2009). 
These blooms increase the turbidity of aquatic ecosystems, smothering aquatic plants 
and thereby suppressing important invertebrate and fish habitats (Paerl and Huisman, 
2008). Die-off of blooms may deplete oxygen, killing fish (Paerl and Huisman, 2008). So 
the high nutrient loading, rising temperatures, enhanced stratification (reducing vertical 
mixing), increased residence time, and salination are all factors that promote 
cyanobacterial dominance in many aquatic ecosystems (Paerl and Huisman, 2008).  
The occurrence of cyanobacterial mass populations can create a significant water 
quality problem, especially as many cyanobacterial species are capable of synthesizing a 
wide range of noxious compounds or potent toxins (cyanotoxins) (Sivonen and Jones, 
1999).  
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1.2. Cyanotoxins 
Cyanotoxins can be divided following two main criteria (Sivonen and Jones, 1999): 
 On the basis of their mechanism of action on terrestrial vertebrates, especially 
mammals (hepatotoxins, neurotoxins, dermatoxins, cytotoxins and irritant toxins); 
 According to their chemical structure (cyclic peptides, alkaloids or 
lipopolyssacharides); 
Table 1 shows the main cyanotoxins, the producing cyanobacteria and their 
mechanism of action. 
Table 1. Cyanotoxins, the producing cyanobacteria and mechanism of action. 
Toxin Cyanobacteria genera Mechanism of action 
Microcystins 
Microcystis 
Inhibition protein phosphatase 
(PP1 and PP2A) 
Anabaena 
Plankthotrix 
Nodularin Nodularia 
Inhibition protein phosphatase 
(PP1 and PP2A) 
Saxitoxins 
Anabaena 
Binding and blocking the sodium 
channels in neural cells 
Aphanizomenon 
Cylindrospermopsis 
Lyngbya 
Anatoxins 
Anabaena 
Binding irreversibly to the nicotinic 
acetylcholine receptors 
Aphanizomenon 
Cylindrospermopsis 
Plankthotrix 
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Oscillatoria 
Microcystis 
Anatoxin-a (s) Anabaena 
Inhibition of acetylcholinesterase 
activity 
Cylindrospermopsin 
Cylindrospermopsis 
Inhibitor of protein biosynthesis 
cytogenetic damage on DNA 
Aphanizomenon 
Umezakia 
Raphidiopsis 
Anabaena 
Lipopolysaccarides Cyanobacteria in general 
Irritant; causes inflammation in 
exposed tissues 
BMAA Cyanobacteria in general 
Binding to the glutamate receptors, like 
NMDA, AMPA and mGluR 
1.3. History and relevance of BMAA 
β-N-methylamino-L-alanine (BMAA) is a neurotoxic non-protein amino acid produced 
naturally by cyanobacteria found in freshwater, marine and terrestrial ecosystems (NIEHS, 
2008). This toxin was first isolated by Vega and Bell (1967) from cycad seeds, in Guam 
(Pacific Ocean) (Cohen, 2012). Among Chamorro people of Guam the incidence of 
neurodegenerative illness (mostly Amyotrophic Lateral Sclerosis/Parkinsonism Dementia 
Complex) was one of the highest in the world (Cohen, 2012). Amyotrophic Lateral 
Sclerosis (ALS) is a debilitating and fatal neuromuscular disease and approximately 8–
10% of all cases are familial, about half of which are characterized by superoxide 
dismutase mutation (SOD-1). The other 90–92% of ALS cases occurs sporadically, with 
no known familial history (Banack et al., 2010b). At present, there is no known cause for 
sporadic ALS, though a number of environmental compounds have been implicated as 
potential etiological agents (Banack et al., 2010b). BMAA has been linked to the high 
incidence of the neurodegenerative disease amyotrophic lateral sclerosis/parkinsonism-
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dementia complex (ALS/PDC) among the indigenous Chamorro people on the islands of 
Guam (Cox et al., 2003). BMAA was present throughout cycad tissues, but was 
particularly abundant in cycad seeds and immature pollen (Banack and Cox, 2003). The 
cycad seeds are washed and used as flour by the indigenous Chamorro people, and they 
are also used as food by wild animals including flying foxes, pigs and deer (Cohen, 2012). 
The suggested link between BMAA and ALS/PDC in Guam is because of (Pablo, 2009): 
 BMAA is produced by cyanobacteria, including endosymbiotic species of Nostoc (a 
genus of cyanobacteria) found in cycad roots; 
 BMAA occurs in higher amounts in cycad flour than was previously suspected 
because of its occurrence in the protein fraction (i.e., BMAA binds to a protein); 
 BMAA can be biomagnified in animals which forage on cycad seeds and are 
subsequently consumed by the Chamorro people. 
The biomagnification was reported by Murch et al. (2004b), where they observed the 
biomagnification at Guam ecosystem. In this study, BMAA was found as protein-bound in 
symbiont-cyanobacteria (namely Nostoc) of Cycas micronesica (between 2 and 738 µg/g), 
in cycad flour (between 49 and 168 µg/g) and in flying foxes (between 2 and 146 µg/g). 
The same authors found that BMAA, both as a free amino acid and as a protein-
bound amino acid, occurs in the brain tissues of Chamorro patients who died from 
ALS/PDC (Murch et al., 2004a). Thus, a trophic chain where BMAA was present from 
primary producers to the consumers was found.  
BMAA was, also, detected in the brains of Canadian patients with Alzheimer’s 
disease but not in control patients without neurological disease (Murch et al., 2004a). 
Another interesting finding was made by Pablo et al. (2009), that showed the presence of 
BMAA in the brains of USA patients, but not in those of patients with Huntington’s disease 
(a genetic neurodegenerative disease) (Pablo et al., 2009). The negative screen for 
BMAA in Huntington’s disease, suggests that BMAA does not occur as a byproduct of 
neurodegenerative disease (Pablo et al., 2009; Banack et al., 2010b). 
The fact that it was reported that all known groups of cyanobacteria can produce 
BMAA allowed more studies of bioaccumulation in aquatic environment (Cox et al., 2005), 
especially in marine ecosystems, where many organisms from different trophic levels 
presented BMAA (Brand et al., 2010; Jonasson et al., 2010).  
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1.4. Physical and chemical properties of BMAA 
BMAA is a polar, non-protein basic amino acid. Some chemical and physical 
properties are shown in table 2. 
Table 2. Chemical and physical properties of BMAA (adapted from NIEHS, 2008). 
Synonyms: L-β-Methylaminoalanine 
β-methylamino-L-alanine 
(+)-L-β-N-Methyl-α,β-diaminopropionic acid 
L-α-amino-β-methylamino propionic acid 
L-MeDAP (methylated α,β-diaminopropionic acid) 
IUPAC: (2S)-2-amino-3-(methylamino)propanoic acid 
CAS Registry No: 15920-93-1 
Molecular formula: C4H10N2O2 
Molecular weight: 118,1344 g/mol or Da 
BMAA is an amino acid and can be found as L- and D-α-amino-β-
methylaminopropionic (Vega et al., 1968). Vega and colleagues (1968) reported that the 
D- isomer was not toxic when injected in chicks and young rats in comparison with the L- 
isomer that produced a toxic effect. The last isomer was the one isolated in seeds of 
Cycas circinalis (Vega and Bell, 1967). 
Many different isomers of BMAA have been reported and when the objective of the 
study is to detect and quantify this neurotoxin, these isomers have to be considered. From 
these isomers the most reported in literature are DAB (2,4-diaminobutyric acid) and AEG 
(N-(2-aminoethyl) glycine), that are molecular isomers. DAB is believed to be a 
hepatotoxic and neurotoxic non-protein amino acid that is found in many prokaryotic and 
eukaryotic organisms (Jiang et al., 2012). AEG is a backbone for peptide nucleic acids 
and its effects have not yet been discovered (Banack et al., 2012). In figure 1 it’s show the 
structure of BMAA, DAB and AEG. 
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Figure 1. Structure of BMAA and selected isomeric compounds (DAB and AEG) (adapted 
from Jiang et al., 2012). 
1.5. Mechanism of action of BMAA 
The BMAA that is bound to proteins within the body can slowly be released into 
cerebral tissues in the free form when these proteins are metabolized over time, acting as 
an endogenous neurotoxic reservoir (Murch et al., 2004a; Cox et al., 2005). BMAA has 
been found to induce selective motor neuron (MN) loss in dissociated mixed spinal cord 
cultures at concentrations of approximately 30 μM, significantly lower than those 
previously found to induce widespread neuronal degeneration and supporting the 
hypothesis that BMAA may contribute to the selective MN loss in ALS/PDC (Rao et al., 
2006; Lobner et al., 2007).  One mechanism of action of this toxin is excitotoxicity. This 
type of toxicity is characterized by malfunctions in EAAs (excitatory amino acids – 
neurotransmitters within the nervous system) that can lead to neurons being damage and 
fatally compromised (Chiu et al., 2011). Excitotoxic cell death involves prolonged 
depolarization of neurons, changes in intracellular calcium concentrations, and the 
activation of enzymatic and nuclear mechanism of cell death (Doble, 1999). AMPA 
(quistalate/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), NMDA (N-methyl-D-
apartate) and mGluR (metabolic glutamate receptors) are the main EAA receptors, all of 
which are activated by glutamate and similar substances (Chiu et al., 2011). Many studies 
shown that excitotoxicity is a main player in neurodegenerative disease, because there is 
an increased level of glutamate found in the cerebrospinal fluid of ALS patients (Majoor-
Krakauer et al., 2003; Shaw, 2005). So, when BMAA is orally consumed, 80% of ingested 
BMAA passes from the gut into the blood stream (Chiu et al., 2011). BMAA then crosses 
the blood-brain barrier via large neutral amino acid carriers (Chiu et al., 2011). It is known 
that physiological concentrations of bicarbonate ions react with BMAA to form β-
carbamate, and in this form BMAA can compete in binding to various glutamate receptors, 
like NMDA receptors, AMPA receptors and mGluR (Banack et al., 2010b; Rao et al., 
2006). The activation of this receptors leads to shifts in cellular ion concentrations 
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resulting in increases in Na+ and Ca2+, and a decrease in K+ concentrations, and also 
causes the cell to become depolarized leading to permeabilisation of the cell membrane, 
resulting in the release of noradrenalin (Chiu et al., 2011). BMAA also inhibits the 
cysteine/glutamate antiporter system Xc-, preventing the uptake of cysteine, resulting in 
glutathione depletion, which contributes to increases in oxidative stress (Liu et al., 2009). 
At the same time the system Xc- increases the release of glutamate from the cell (Liu et 
al., 2009). Glutamate can then bind to glutamate receptors increasing damage by 
excitotoxicity. Increases in intracellular Ca2+ concentrations disrupt normal mitochondrial 
function leading to the release of ROS (reactive oxygen species) into the cytoplasm, 
thereby contributing to the observed increases in oxidative stress (Lobner et al., 2007). In 
addition, cytochrome-c is released from mitochondria resulting in the induction of 
apoptosis (Chiu et al., 2011).  
Beside this mechanism of action, it has also been suggested that BMAA can be 
incorporated into proteins and subsequently lead to protein misfolding (Banack et al., 
2010b). The tRNA synthetase enzyme for the amino acid serine mistakenly picks up 
BMAA and incorporates it into proteins in vitro (Holtcamp, 2012). Because of this 
misincorporation and consequent occurrence of mistakes in translation, the hydrophobic 
parts of the protein end up exposed. These parts adhere to other misfolded proteins, 
forming “aggregates”, a characteristic of neurodegenerative diseases. The formation of 
small aggregates seeds the formation of larger, more toxic aggregates in a sort of chain 
reaction that prevents the cells from functioning effectively (Holtcamp, 2012). 
These multiple mechanisms of BMAA toxicity may account for its ability to induce 
complex neurodegenerative diseases (Banack et al., 2010b). 
1.6. Analysis of BMAA 
Concerning the analysis of BMAA, different methods have been used. High 
performance liquid chromatography with fluorescence detection (HPLC-FLD) (Cox et al., 
2005; Banack et al., 2007; Johnson et al., 2008; Metcalf et al., 2008; Eriksson et al., 2009; 
Cianca et al., 2012a), gas chromatography with mass spectrometry detection (GC-MS) 
(Esterhuizen and Downing, 2008), capillary electrophoresis (CE) (Baptista et al., 2011), 
amino acid analyzer (Banack et al., 2007), nuclear magnetic resonance spectroscopy 
(Moura et al., 2009), liquid chromatography with tandem mass spectrometry detection 
(LC-MS/MS) (Kubo et al., 2008; Rosén et al., 2008; Faassen et al., 2009; Banack et al., 
2010a; Kruger et al., 2010; Li et al., 2010; Spácil et al, 2010; Jonasson et al., 2010), and 
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more recently commercial enzyme linked immunosorbent assay (ELISA) (Faassen et al., 
2013), have been reported for the measurement of BMAA. It was hypothesized that 
different analytical methods for the determination of BMAA deviate in their results 
(Faassen et al., 2012). For example, high BMAA concentrations and high percentages of 
positives samples were found only in those studies that had used HPLC-FLD (Cox et al., 
2005; Metcalf et al., 2008), GC-MS (Esterhuizen and Downing, 2008) or CE (Baptista et 
al., 2011). On the other hand, studies that had used LC-MS/MS for quantification either 
did not detect BMAA, or reported lower BMAA concentrations (Rosén and Hellenas, 2008; 
Faassen et al., 2009; Jonasson et al., 2010; Kruger et al., 2010). Faassen et al. (2012) 
concluded, in their study, that HPLC-FLD overestimated BMAA concentrations in some 
cyanobacterial samples due to its low selectivity. They also recommended to only use 
selective and sensitive analytical methods like LC-MS/MS (with derivatization or not) for 
BMAA analysis (Banack et al., 2010a; Faassen et al., 2012).  
Another difference that occurs in these studies is the use (or not) of derivatization. 
Because BMAA has no chromophore, it needs to be derivatized in order to be detected by 
fluorescence (Cianca et al., 2012b). Derivatization is also used with LC-MS/MS, because 
the electrospray ion source (ESI) desorption of charged molecules occurs from the 
surface, meaning that sensitivity is higher for compounds with a greater concentration at 
the surface of the droplet, thus the more lipophilic ones (Banack et al., 2010a). The 
derivatized compounds are more lipophilic compared to underivatized ones and also have 
higher molecular weight, being easier to detect (Banack et al., 2010a).  
However, some concerns are given to the use of derivatization. This step in the 
sample preparation can interfere in the results, since there is a theoretical risk that a 
compound similar to BMAA would react to give a BMAA-derivative during the 
derivatization procedure (Rosén and Hellenas, 2008). So, many investigators have used 
methods of analysis of BMAA without using derivatization (Kubo et al., 2008; Rosén and 
Hellenas, 2008; Faassen et al., 2009; Faassen et al., 2012).  
1.7. Bioaccumulation of BMAA and ways of exposure 
The bioaccumulation of cyanotoxins by aquatic organisms is widely described in 
literature. Several of these studies have shown that mollusks are the most frequent 
organisms that are able to accumulate cyanotoxins, like mycrocystin-LR (Vasconcelos, 
1995; Pires et al., 2004), PSP (Pereira et al., 2004), nodularin (Karlsson et al., 2003), 
cylindrospermopsin (Saker et al., 2004) and anatoxin-a (Osswald et al., 2008).  
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Since BMAA was found to be synthesized from cyanobacteria and is not a byproduct 
of neurodegeneration (Pablo et al., 2009), the identification of BMAA, not only in the 
brains of ALS/PDC patients who died in Guam, but also of patients who had died of 
Alzheimer’s disease in Canada and USA, suggests that exposure to cyanobacterial 
neurotoxins exists outside Guam and that BMAA may be more widely distributed than 
previously supposed (Murch et al., 2004a; Bell, 2009).  
This was further evidenced by the finding that BMAA can be produced by all known 
groups of cyanobacteria, including cyanobacterial symbionts and free-living cyanobacteria 
(terrestrial, as well as freshwater, brackish, and marine) (Cox et al., 2005). In British 
waterbodies, Metcalf et al. (2008) reported the presence of BMAA in samples of 
cyanobacteria from different blooms. They also showed that BMAA can co-occur with 
others cyanotoxins, including microcystins, anatoxin-a, nodularin and saxitoxin (Metcalf et 
al., 2008). In Portuguese estuaries, free and protein bound BMAA were found in 
cyanobacteria (Cianca et al., 2012b). 
 Esterhuizen et al. (2011) showed that free BMAA can be released during the 
collapse of cyanobacterial blooms. This process combined with cellular turnover creates a 
latent source of the non-protein amino acid for bioaccumulation and biomagnification in 
aquatic ecosystems. Following accumulation of free BMAA, protein association was 
observed which suggests a potential route for human exposure to BMAA (Murch et al., 
2004b; Esterhuizen et al., 2011). As it was early recognized, BMAA can be biomagnified 
in animals on Guam ecosystem (Cox et al., 2003; Banack et al., 2006).The evidence of 
the widespread occurrence of BMAA, suggest that bioaccumulation of BMAA could occur 
within other organisms outside of Guam (Cox et al., 2005).  
Several studies have reported the presence of BMAA in animals in marine 
environment, evidencing that some transfer exist through trophic chain. For example, 
Brand et al. (2010) found that many crustaceans appear to have high concentrations of 
BMAA (7000 µg/g) in South Florida, where it is usual to occur many blooms of 
cyanobacteria.  
In the Baltic Sea was found that BMAA is biosynthesized by cyanobacteria (Jonasson 
et al., 2010). Like in South Florida, BMAA was also found in organisms of higher trophic 
levels that directly or indirectly feed on cyanobacteria, such as zooplankton (87 ng/g) and 
various vertebrates (fish) and invertebrates (mussels, oysters), where concentrations 
ranging from 10 ng/g to 1290 ng/g were found (Jonasson et al., 2010). 
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It was also reported levels of BMAA in feathers of Lesser Flamingo (77 ng/g), which 
consume cyanobacteria as a major part of their diet, in Kenyan lakes (Metcalf et al., 
2013). 
 
Figure 2. BMAA transfer in an aquatic trophic chain (adapted from Jonasson et al., 2010). 
Therefore, human population may potentially be exposed to BMAA from water 
sources containing cyanobacteria blooms and consumption of fish or animals that have 
been exposed to BMAA (NIEHS, 2008).  
Another postulated route of cyanotoxin exposure is inhalation of aerosolized toxins 
(Banack et al., 2010b). There are many examples of toxin aerosolization leading to human 
illness (Stommel et al., 2013). An example is the brevetoxin that can be aerosolize 
through wave action of marine waters, causing asthma like syndrome (Fleming et al., 
2007). Other example is the generation of aerosolized microcystin, making inhalation a 
potential route of exposure (Backer et al., 2008). Consequently, Stommel et al. (2013) 
hypothesize that white caps on waterbodies containing cyanobacterial blooms and 
cyanobacteria present on cooling towers, could result in aerosolization of BMAA. 
15 ng/g
87 ng/g
1290 ng/g
201 ng/g
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1.8. Objectives 
The objective of this work was to obtain data about the potential transfer of BMAA 
from cyanobacteria to marine invertebrates, which are part of the human trophic chain.  
For this, two different species of marine invertebrates, with different ways of feeding 
were chosen. Mytilus galloprovincialis (a filter feeder) and Gibbula umbilicalis (a grazer) 
were fed with cyanobacteria, growing in laboratory, that had been isolated from 
Portuguese northern estuaries, to determine BMAA uptake, in a bioaccumulation 
experiment in which different periods of feeding and depuration were tested. 
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2. Material and Methods 
2.1. Species ecology 
M. galloprovincialis (blue mussel or Mediterranean mussel) is native to the 
Mediterranean coast and the Black and Adriatic Seas. This mussel is dark blue or brown 
to almost black. The two shells are equal and nearly quadrangular. The outside is black-
violet colored. On one side the rim of the shell ends with a pointed and slightly bent umbo 
while on the other side is rounded, although the shape of the shell can vary from region to 
region.  
In its native range, M. galloprovincialis can be found from exposed rocky outer coasts 
to sandy bottoms (Ceccherelli and Rossi, 1984). It typically requires rocky coastlines with 
a high rate of water flow. 
Regarding the nutrition, M. galloprovincialis is a filter-feeding bivalve that eats a wide 
range of planktonic organisms. This species prefers fast moving water that is free of 
sediment and thrives in regions where nutrient-rich upwelling occurs. This mussel is an 
important component of estuarine and marine food webs and because it is a sessile filter 
feeder, it may be exposed to high density of cyanobacteria and their toxins (Osswald et 
al., 2008). 
G. umbilicalis is found on the European coasts of the Atlantic Ocean. This sea snail 
belongs to the Trochidae family. It is found from the upper shore into the sublitoral on 
sheltered rocky shores and is tolerant of emersion and brackish waters. It is characterized 
by having a small top shell, broader, rounded and flatter. It also has a large round 
umbilicus (a deep hole on the underside of the shell). Concerning other features, it is 
greenish-grey in color and has broad diagonal stripes of reddish-purple. They live as 
algae grazers and detritus eaters. These species are not normally used in 
bioaccumulation studies. However, recently, it was shown that levels of tetrodotoxin were 
detected in G. umbilicalis (Silva et al., 2012; Silva et al., 2013).  
These two species are used as food by other animals (including humans), providing a 
way of exposure to cyanotoxins, namely BMAA, through food chain. 
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2.2. Cyanobacteria culture growth 
Previous studies regarding BMAA production and cyanobacteria characterization 
served as the basis for the choice of species (Cianca et al., 2012b; Brito et al., 2012). The 
cyanobacteria were isolated as described in Lopes et al. (2010) and kept growing at 
LEGE laboratory (CIIMAR) as part of the culture collection. The selected strains of 
cyanobacteria were grown in BG11 (Rippka et al., 1979) and MN (Waterbury and Stanier, 
1978) and Z8 (Kotai, 1972) growth media for two weeks, at 25ºC of temperature and 
under light intensity of 20,8 – 27,4x10-6 E m-2 s-1 and a light/dark cycle of 14/10 h (figure 
3). Some modifications were introduced in the culture media, namely in BG11
15N (a variant 
of the BG11 medium), in which labeled 
15N was delivered as 15NH4Cl (table 3). 
Table 3. Cultured cyanobacteria strains. 
LEGE code Strain Medium Environment 
#06077 Nostoc sp. MN Estuary 
#06077 Nostoc sp. BG11
15N Estuary 
#06079 Synechocystis salina BG11
15N Estuary 
#06079 Synechocystis salina Z8 Estuary 
The cells were grown to obtain enough biomass to feed the animals (105 cells/mL). At 
the end of the experiment the cells were harvested by centrifugation. Afterwards, all 
samples were lyophilized and stored at -20ºC. 
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Figure 3. Cyanobacteria culture room. 
2.3. Bioaccumulation experiment  
The collection of M. galloprovincialis and G. umbilicalis was done in a beach at 
Matosinhos, Portugal (figure 4). These mussels and sea snails were, then, placed in 
aquariums in BOGA (Biotério de Organismos Aquáticos) at CIIMAR for acclimation during 
one week. The aquariums had capacity for 20 L and had aeration. These were filled with 3 
L of marine water and every two days the water was changed. Some sea snails and 
mussels were also collected from the beach and frozen (without any treatment) for 
subsequent analysis. 
  
Figure 4. Sampling site of M. galloprovincialis and G. umbilicalis at Matosinhos. 
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2.3.1. Mussels exposed to BMAA standard 
M. galloprovincialis were exposed to BMAA standard (Sigma – Aldrich) with 
concentrations of 1, 2,5 and 5 mg/L for periods of 24 h and 48 h. The BMAA standards 
were dissolved in the seawater and four individuals were exposed to each concentration. 
The mussels were not fed. One death was observed during this experiment. 
2.3.2. Mussels fed with cyanobacteria 
Approximately sixty individuals kept in 20 L aquariums and aerated, were fed with S. 
salina, growing in Z8 medium, every two days (figure 5A). The water was changed every 
two days. The mussels were collected after 4, 8 and 10 days of feeding and at the end of 
the experiment after allowing 10 days of depuration. No deaths were observed during this 
experiment. 
Control mussels, kept in a separate aquarium, were fed with the green algae 
Chlorella sp. grown as described in 2.2. 
2.3.3. Sea snails fed with cyanobacteria 
G. umbilicalis were placed in 20 L aquariums and aerated (120 organisms in each), 
as described before, and fed with S. salina, growing in BG11
15N culture media, and Nostoc 
sp., one growing in MN culture medium and the other one in BG11
15N, every two days 
(figure 5B). The water was also changed every two days. 
Chlorella sp. was used as control. After 5, 10 and 15 days of feeding, and 5 days of 
depuration, the sea snails were collected. Five deaths were observed during this 
experiment. 
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Figure 5. Aquariums with M. galloprovincialis (A) and G. umbilicalis (B). 
2.4. Acid microwave-assisted extraction 
The soft parts of the body of the mollusks were removed from their shells, weighted 
and digested. 
Usually, the hydrolysis step to extract BMAA uses 6 M HCl at 110ºC, with times of 
digestion varying from 12 to 24 h (Faassen et al., 2009; Jonasson et al., 2010). However, 
Baptista et al. (2011) suggested this step could be performed using a microwave system. 
The main advantages of the microwave-assisted digestion are the shorter time of the 
procedure, the possibility to control the temperature and/or the pressure inside the 
microwave vessels, and the possibility to process a larger number of samples at the same 
time (Baptista et al., 2011). 
To optimize the microwave-assisted hydrolysis of BMAA three different programs 
were tested. Time, temperature and power of the hydrolysis were varied as shown in table 
4. For that, 1 mg/L BMAA standard (1 replica) was transferred to closed PTFE vessels 
and digested using a high-pressure microwave system (Milestone-Ethos1). 
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Table 4. Programs used for the optimization of the microwave-
assisted hydrolysis. 
Power (W) Temperature (ºC)  Time (min) 
300+400+500 >50 5+5+5 
300 >50 10 
<1000 90 20 
Mussels exposed to BMAA standard and mussels and sea snails fed with 
cyanobacteria and cyanobacteria biomass were digested with 2 mL of 6 M HCl, for 20 min 
at 90ºC, 10 mg per sample. Three replicas per sample were digested. The complete 
dissolution of the biomass was achieved as verified by the clarity of the digest. Afterwards 
the samples were evaporated under a low flux of nitrogen. 
2.5. Enzymatic digestion 
Mussels and sea snails fed with cyanobacteria were also digested with digestive 
enzymes, namely proteases: pepsin, trypsin and chymotrypsin.  
The enzymatic digestion was performed according to Bauer et al. (2003), with minor 
modifications. The reagents used for this method were prepared as follows: 
 Pepsin/HCl solution: 0,8 g of pepsin was dissolved in 500 mL of HCl solution (4,25 
mL HCl  and water);  
 Trypsin/Chymotrypsin solution: 0,9 g of each enzyme were dissolved in a pH 7,8 
phosphate buffer (560 mL of Na2HPO4 0,165 mol/L and 440 mL of KH2PO4.12H2O 
0,165 mol/L) 
 HCl/Acetic acid solution: HCl (1 mol/L) and acetic acid (1 mol/L) were combined in 
a ratio of 5:2. 
Samples were digested with pepsin, or with trypsin/chymotrypsin. For the pepsin 
digestion the samples were incubated in 50 mL tubes with 8,5 mL of pepsin/HCl solution. 
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For the trypsin/chymotrypsin digestion the samples were incubated in 50 mL tubes with 10 
mL of trypsin/chymotrypsin solution. At the end of the digestion the solution was 
neutralized by addition of 1,6 mL of HCl/acetic acid solution. 
Three replicas of 100 mg samples were made for each digestion. The samples were 
incubated in a water bath, at 37ºC, for 2 h with constant stirring. After this, the samples 
were centrifuged and the supernatant was collected. All samples were then pre-
concentrated using solid-phase extraction (SPE). 
2.6. SPE 
Mussels and sea snails digested with enzymes and sea snails digested with HCl were 
pre-concentrated by solid-phase extraction using a cartridge Isolute HCX-3, 100 mg 
(Biotage) and the cleanup procedure described by Spácil et al (2010). The solid phase 
column was pre-conditioned with 1 mL MeOH. After that, it was conditioned with 2 mL 
0,1% formic acid/H2O.  
HCl digested samples were reconstituted in 1 mL of 0,1% formic acid/H2O and 
applied to the column. The enzymatically digested samples were applied to the SPE 
column. The washing step was done using 1 mL 0,1% formic acid/H2O, followed by a two-
step elution. The first elution step consisted of 1 mL 0,1% formic acid in 25% MeOH. The 
second elution step consisted of 1 mL 2% NH4
+ in MeOH. Both eluates were evaporated 
using a freezdrier (-110ºC, vacuum). 
2.7. LC-MS/MS analysis 
2.7.1. Analysis without derivatization 
Liquid Chromatography with mass detection (LC-MS/MS) without derivatization was 
used to measure BMAA in cyanobacteria and mussels samples. The samples were 
reconstituted with 20 mM HCl, before the analysis with LC-MS/MS. 
Analyses were performed using a system that comprised a LC (Thermo Scientific) 
coupled to a MS (Thermo Scientific, LCQ Fleet) with an ESI interface. The electrospray 
interface was operated using the following settings: positive polarity and nebulizer, N2 (1,5 
20 
L/min; drying gas, N2 at 0,1 Mpa). Full-scan MS was performed from m/z 50 to 150 at 0,5 
s–1 scan in the continuum mode. LC conditions were as follows: column, ZIC-HILIC (100 
mm x 2,1 mm; with guard column); mobile phase of 90–60% aqueous linear gradient of 
acetonitrile (ACN) for 20 min, then 60% aqueous ACN maintained for 15 min; flow rate of 
0,5 mL/min; column temperature, 40ºC; and CE 16,0 (collision energy) .  
To obtain an analytical curve and to determine the detection limit for BMAA, 
standard BMAA solutions (10 µg/L to 1000 µg /L), which were prepared using 20 mM HCL 
as the solvent, were used (Kubo et al., 2008).  
Selected specific product ions (m/z 102, 88, 73), all derived from the precursor ion 
m/z 119 (BMAA molecular weight (M + H+)) and originated from different parts of the 
molecule were selected. The ion used for quantification was m/z 119, whereas the other 
two ions were used as qualitative. These products were detected in previous LC-MS/MS 
analysis of BMAA (Rosén and Hellenas, 2008). Excalibur V2.1 software was used to 
explore acquired chromatographic data. The limit of detection was 1,7 pmol/injection. 
2.7.2. Analysis with derivatization 
Liquid Chromatography with mass detection (LC-MS/MS) with derivatization was 
used to measure BMAA in cyanobacteria, sea snails and mussels samples. 
Standards and samples were derivatized with AQC - 6-aminoquinolyl-N-
hydroxysuccinimidyl carbamate (Waters AccQ·tag ultra-kit, Milford, MA, USA). All 
chemicals used for the reaction were supplied with the kit and solutions were applied as 
follows: 20 µL of 20 mM HCl was added to redisolve the dried sample pellet, then 70 µL of 
borate buffer was added followed by 30 µL ACQ tag. The sample was then vortexed and 
analyzed within 48 h. ESI ionization was performed in positive ion detection mode. The 
mass analyzer used SRM scan type with recorded transitions: 459,1>119,1 (CE 30,0), 
DAB 459,1>188,0 (CE 38,0), AEG 459,1>214,1 (CE30,0), BMAA 459,1>258,0 (CE 30,0). 
Other parameters of the ESI source and the mass analyzer are listed below: capillary 
voltage (5500V), source temperature (450C), declustering potential (50), focusing 
potential (350), and entrance potential (6). 
The LC system was an Acqutiy UPLC Xevo, TQ-MS with an Acquity UPLC, BEH C18, 
1,7 µm, 2,1 x 100 mm column. Eluent A was 0,01% formic acid in 0,05% ammonia and 
water; eluent B was 0,01% formic acid in methanol. The elution program was applied as 
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follows: 0,0%A till 4,00 min; 99,9%A 0,1%B till 4,10 min; 45%A 45%B till 4,70 min; 100%B 
till 6,00 min; 99,9%A 0,1%B till end. To obtain an analytical curve and to determine the 
quantification limit for BMAA, standard BMAA solutions (1 µg/L to 1000 µg/L), which were 
prepared using 20 mM HCL as the solvent, were used. The ion used for quantification was 
m/z 119, whereas the m/z 258 was used as qualitative. MassLynx V4.1 software was 
used to explore acquired chromatographic data. The limit of detection was 0,4 
pmol/injection.  
2.8. Metabolic activity of cells of mussels fed with 
cyanobacteria 
The primary cells for this experience were obtained as previously described by 
Louzao et al. (2010). Mussel gills and hepatopancreas, from the mussels fed with 
cyanobacteria, were excised, separately washed in ice-cold sea water and sliced with a 
bistoury in small fragments. Then, gills and hepatopancreas portions were immersed in 
ice-cold sea water and gently agitated with a magnetic stirrer. After washing for 15 min the 
slices were rinsed twice with fresh ice-cold sea water and filtered through 200 µm nylon 
meshes three times. Finely chopped 5-10 g of gills and hepatopancreas tissues were 
enzymatically dispersed with 3500 IU/mL collagenase and 1 IU/mL dispase in 20 mL of 
artificial sea water for 45 min at 37ºC (Louzao et al., 2010). The treatment resulted in a 
suspension containing the cells, which were harvested by centrifugation at 800 rpm for 5 
min. 200 μL of the cell-containing suspension were seeded on 96-well plates. Three 
replicates of each sample were made. 20 μL of Alamar Blue (Biosource; Invitrogen 
Corporation), diluted 1:5, was added and fluorescence was measured using a microplate 
reader (Biotek synergy HT). Cells were incubated in constant shaking at room 
temperature, and measurements were registered at 2,5; 5 and 20 h. Fluorescence was 
monitored at 530-560 nm excitation wavelength and 590 nm emission wavelength.  
The Alamar Blue Assay incorporates a fluorometric/colorimetric growth indicator 
based on detection of metabolic activity. Specifically, the system incorporates an 
oxidation-reduction (REDOX) indicator that both fluoresces and changes color in response 
to chemical reduction of growth medium resulting from cell growth (Ahmed et al., 1994). 
The REDOX indicator exhibits both fluorescence and colorimetric change in the 
appropriate oxidation-reduction, is demonstrated to be minimally toxic to living cells and 
produces a clear, stable distinct change which is easy to interpret. Metabolic activity of the 
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cells being tested results in a chemical reduction. Continued metabolic activity maintains a 
reduced environment while inhibition of metabolic activity results in an oxidized 
environment. Reduction causes the REDOX indicator to change from oxidized (non-
fluorescent, blue) form to reduced (fluorescent, red) form. Fluorescence is proportional to 
the number of metabolic active cells. 
2.9. Chemicals and reagents 
L- BMAA hydrochloride, its structural isomer DAB and AEG, formic acid, ammonia, 
HCl p.a. 37% (hydrochloric acid) were purchased from Sigma-Aldrich. The enzymes used, 
were purchase, also, from Sigma-Aldrich. The AccQTagfluor (AQC) reagent Kit was 
purchased from Waters Corporation. Acetonitrile, methanol and chromatographic-grade 
water was obtained from VWR. The deionized water (dH2O) had a conductivity < 0,1 
µS/cm. Alamar Blue was from BiosourceTM, Invitrogen Corporation. 
2.10. Statistical analysis 
BMAA content results are the mean values of four or three independent replicates. A 
t-test or a one-way analysis of variance (ANOVA) was performed to test for significant 
differences in mean concentration. Whenever significant differences were found (p ≤ 0,05) 
a Tukey test was performed, using SPSS 21 Software. 
The uptake rate was calculated dividing the mean concentration by the hours of 
exposure. 
For the metabolic activity assay, the growth rate was calculated using the follow 
formula: ln(Cf/Ci), where ln is natural logarithm, the Cf is final concentration and Ci is 
initial concentration. 
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3. Results 
3.1. Microwave-assisted extraction optimization 
To optimize BMAA hydrolysis, using a microwave, three different programs were 
tried. The acid microwave-assisted digestion was used before for BMAA extraction from 
cyanobacteria (Baptista et al., 2011). As far as we know, this method was not yet used for 
BMAA extraction from animals, in these case marine invertebrates. So, we optimized this 
technique to obtain higher recovery efficiency of BMAA.  
 Table 5 shows the comparison of the 1000 µg/L BMAA standard recoveries, after 
different microwave-assisted hydrolysis. 
Table 5. Comparison of the 1000 µg/L BMAA standard recoveries after 
different microwave-assisted hydrolysis, with different time, temperature 
and powers. 
Power (W) Temperature (ºC)  Time (min) %BMAA recovery  
300+400+500 >50 5+5+5 42,72 
300 >50 10 27,94 
<1000 90 20 96,14 
By comparing the BMAA standard recoveries, it can be seen that the program with 90 
ºC, 20 min and power limited to under 1000 W presents the best recovery, with 96,1%. 
The recovery percentages obtained with the BMAA standard shows that this extraction 
technique is suitable. 
With these results, it was decided to compare the calibration curve of hydrolyzed 
standards of BMAA with the calibration curve of non-hydrolyzed aqueous standards and 
see if there was any difference between them. The figure 6 shows that comparison. 
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Figure 6. Calibration curve of BMAA standards hydrolyzed at 90 ºC during 20 min and 
non-hydrolyzed aqueous standards. The trend line colored with dark pink correspond to 
the hydrolyzed standards and the trend line colored with light pink corresponds to non-
hydrolyzed standards. 
It can be seen that both exhibited the same calibration curve. The slopes were 
similar, meaning that there are practically no losses of BMAA during the hydrolysis. A t-
test was made and no significant differences were observed. 
Mussel samples spiked with BMAA standards were digested in the same way. The 
results obtained were compared with the BMAA hydrolyzed standards. The slopes 
obtained were statistically different (p ≤ 0,05) and for that reason the quantification of 
BMAA in mussel samples was made by using the calibration curve of mussels spiked with 
BMAA standard (figure 7). 
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Figure 7. Calibration curves of hydrolyzed standards and hydrolyzed mussels. The trend 
line colored with dark pink correspond to the hydrolyzed standards and the trend line 
colored with light pink corresponds to hydrolyzed mussels. 
The same was made with G. umbilicalis, where it was compared the calibration curve 
of snails spiked with BMAA standard and the calibration curve of BMAA hydrolyzed 
standards (figure 8). 
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Figure 8. Calibration curves of hydrolyzed standards and hydrolyzed sea snails. The 
trend line colored with dark pink correspond to the hydrolyzed standards and the trend line 
colored with light pink corresponds to hydrolyzed sea snails. 
From the figure it is possible to see that the two curves are different. The slopes are 
significantly different (p ≤ 0,05), so, as it happened with mussels, the quantification of 
BMAA in sea snail samples was made by using sea snails spiked with BMAA standard. 
3.2. Bioaccumulation of BMAA 
3.2.1. Mussels exposed to BMAA standard 
Mussels were able to bioaccumulate BMAA when they were exposed to three 
different concentrations of BMAA standard (1 mg/L; 2,5 mg/L and 5 mg/L) for 24 h and 48 
h (figure 9).  
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Figure 9. BMAA levels (µg/g) in mussels exposed for 24 h and 48 h to different 
concentrations of BMAA (1 mg/L; 2,5 mg/L and 5 mg/L). Bars are the standard error (SE) 
of 4 replicates. * significantly different (p ≤ 0,05). 
As expected, there was an increase of BMAA concentration over time and these 
levels were higher at 5 mg/L. There was a significant difference at 5 mg/L, in both 24 h 
and 48 h, in comparison with the other two concentrations. However, no significant 
differences were observed between 1 mg/L and 2,5 mg/L. 
Table 6 presents the concentration of BMAA on mussels exposed to 1 mg/L; 2,5 mg/L 
and 5 mg/L for 24 h and 48 h, and also the uptake rate for each day. It is possible to see 
that the uptake rate is higher in the first 24 h for any concentration used, and that the 
uptake rate decreased during the second 24 h.  
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Table 6. Concentration of BMAA (µg/g) on mussels exposed to 1 mg/L; 2,5 mg/L and 5 
mg/L for 24 h and 48 h and the respective uptake rate. Mean ± standard error (SE) for 
the concentration of BMAA. 
 BMAA µg/g  
(24 h) 
Uptake rate 
µg/g/h 
(24 h) 
BMAA µg/g 
(48 h) 
Uptake rate 
µg/g/h 
(48 h) 
1 mg/L 41,59 ± 4,27 1,73 52,19 ± 4,43 0,22 
2,5 mg/L 50,62 ± 2,51 2,11 60,87 ± 5,03 0,21 
5 mg/L 171,61 ± 17,01 7,15 176,08 ± 10,53 0,09 
In figure 10 it is possible to see the deceleration of the uptake rates. 
 
Figure 10. Concentration of BMAA (µg/g) in mussels exposed to 1 mg/L, 2,5 mg/L and 5 
mg/L during 24 h and 48 h. 
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3.2.2. Animals fed with cyanobacteria 
3.2.2.1. Cyanobacteria culture 
Previous studies regarding BMAA production by cyanobacteria served as the basis 
for the choice of species (Cianca et al., 2012). To see how much BMAA would be 
incorporated by the species used for the bioaccumulation experiment, it was important to 
quantify the BMAA produced by the cyanobacteria strains used to feed these organisms. 
In case of mussels it was only possible to quantify the BMAA produced by each strain 
after the accumulation experiment. 
Table 7 presents the quantification of BMAA in these strains. The strain of Nostoc sp. 
growth on BG11
15N medium presented the highest concentration of BMAA. On the other 
hand, for S. salina, in both growth medium, the concentration of BMAA was lower than the 
limit of detection (LOD). 
Table 7. BMAA quantification (µg/g) in cyanobacteria strains used to feed the marine 
invertebrates. The different growth medium and organisms are also shown. 
Strain Medium BMAA (µg/g) Organism fed 
Nostoc sp.  
(LEGE#06077) 
BG11
15N 131,78 G. umbilicalis 
Nostoc sp.  
(LEGE#06077) 
MN 43,09 G. umbilicalis 
Synechocystis salina 
(LEGE#06079)  
BG11
15N <LOD G. umbilicalis 
Synechocystis salina 
(LEGE#06079) 
Z8 <LOD M. galloprovincilais 
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3.2.2.2. Mussels fed with cyanobacteria 
Figure 11 presents the levels of BMAA in mussels digested with HCl and fed with 
cyanobacteria during 4, 8 and 10 days and 10 days of depuration. Although the 
concentration of BMAA was similar between 4 days and 8 days, it can be seen an 
increase of that level after 10 days. During the depuration period, there was a decrease of 
concentration of BMAA to 15,29 ± 0,66 µg/g . In terms of concentrations of BMAA, no 
statistically significant differences were observed between the different days of feeding (p 
≤ 0,05). However, a significant difference was observed at the depuration period. 
 
Figure 11. BMAA quantification (µg/g) in mussel samples exposed to BMAA 4, 8 and 10 
days of feeding and 10 days of depuration and acid-digested. The columns colored with 
dark blue corresponds to the feeding period and the column with light blue correspond to 
the depuration period. Bars are the standard error (SE) of 3 replicates. * significantly 
different (p ≤ 0,05). 
Figure 12 shows the uptake rate of BMAA by the mussels during the bioaccumulation 
experiment. This rate was calculated using the concentrations obtained with the samples 
acid-digested. It is possible to see that the rate was maximum in the first 4 days of 
feeding, followed by a decrease of the rate during the rest of the feeding period. During 
the depuration period, and as expected, there was no ingestion, because no 
cyanobacteria were given to the mussels. 
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Figure 12. Uptake rate of BMAA (µg/g/h) by mussels (acid-digested) during the 
bioaccumulation experiment. 
Figure 13 presents the BMAA quantification in mussel samples digested with pepsin. 
 
Figure 13. BMAA quantification (µg/g) in mussel samples exposed to BMAA for 4, 8 and 
10 days of feeding and 10 days of depuration and enzimatically digested with pepsin. The 
columns colored with dark pink correspond to the feeding period and the column with light 
pink corresponds to the depuration period.  Bars are the standard error (SE) of 3 
replicates. * significantly different (p ≤ 0,05). 
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Figure 13 shows an increase of the concentration of BMAA during the feeding period, 
of which the highest concentration obtained was after 10 days with 8,08 ± 3,00 µg/g. A 
decrease during the depuration period was observed (2,29 ± 0,26 µg/g). No statistically 
significant difference was observed between 4 and 8 days (p ≤ 0,05). However, between 4 
days and 10 days and between 10 days and 20 days (depuration period) was observed a 
significant difference (p ≤ 0,05).  
Figure 14 presents the BMAA quantification in mussel samples digested with 
trypsin/chymotrypsin. 
 
Figure 14. BMAA quantification (µg/g) in mussel samples exposed to BMAA during 4, 8 
and 10 days of feeding and 10 days of depuration and enzymatically digested with 
trypsin/chymotrypsin. The columns colored with dark purple correspond to the feeding 
period. Bars are the standard error (SE) of 3 replicates. 
From this figure, it can be seen that only at 4 days and 10 days were observed 
concentrations of BMAA. With 8 days and 20 days it was not possible to quantify the 
BMAA, since the concentrations were lower than de LOD. No significant differences were 
observed between 4 days and 10 days. 
Table 8 shows the different concentrations of BMAA (µg/g) for the different days of 
exposure and for the different digestions used.  It can be seen that the acid digestion was 
the one which removed more BMAA from the sample, followed by the pepsin digestion 
and the trypsin/chymotrypsin digestion.  
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Table 8: BMAA quantification in mussels samples digested with HCl, pepsin and 
trypsin/chymotrypsin. Mean ± standard error (SE) (3 replicates). 
Samples HCl  
(µg/g)  
Pepsin 
(µg/g)  
Trypsin/chymotrypsin 
(µg/g)  
4 days 32,92 ± 15,66 1,19 ± 0,19 1,79 ± 0,99 
8 days 32,65 ± 7,93 5,32 ± 0,94 < LOD 
10 days 41,92 ± 15,13 8,08 ± 3,00 5,79 ± 1,02 
20 days  15,29 ± 0,66 2,29 ± 0,26 < LOD 
The results obtained with samples digested with pepsin were similar with those 
obtained with acid digestion, in which an increase of the level of BMAA could be seen 
during the feeding period followed by a decrease during the depuration period. However, 
the concentrations showed in these samples were lower than the ones obtained with the 
acid digestion. With the samples digested with trypsin/chymotrypsin it was only possible to 
see BMAA after 4 and 10 days of feeding. For 8 days and depuration period no BMAA 
was possible to quantify, since the values were lower than the limit of detection. However, 
it was also possible to see that the concentrations of BMAA obtained with these samples 
were lower than the ones obtained with the acid-digestion and the pepsin digestion. 
All the results concerning BMAA quantification were obtained with the measurement 
of underivatized samples. 
For the derivatized samples no results were obtained. This happened because, 
although in some samples it was possible to see the peak of BMAA, it was not possible to 
quantify since they were lower than the limit of detection.  For example, for the lowest 
standard BMAA used (10 µg/L) the area obtained was 146,8, whereas for sample of 10 
days of exposure it was of 38,9. However, it was possible to see that the area of the 
peaks followed the sample trend as presented here. 
Mussels collect at the beach and mussels fed with Chlorella sp. as control did not 
present BMAA. 
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3.2.2.3. Sea snails fed with cyanobacteria 
All the G. umbilicalis samples were derivatized. No results were obtained with G. 
umbilicalis, for both samples microwave-digested and enzymatically digested, as the 
samples were bellow the LOD.  
3.3. Metabolic activity of cells of mussels fed with cyanobacteria 
Table 9 presents the growth rate of cells isolated from the gills and hepatopancreas of 
M. galloprovincialis that was fed with cyanobacteria for 4, 8, and 10 days, following a 10-
day depuration period.  
Table 9. Growth rate (h-1) of cells from M. galloprovincialis after exposure to the 
Alamar Blue for 2,5 h, 5 h and 20 h. Mean ± standard deviation (SD) (3 replicates). * 
significantly different (p ≤ 0,05). 
Gills 2,5 h 5 h 20 h 
4 days 0,93 ± 0,03 1,35 ± 0,02 1,99 ± 0,02* 
8 days 0,48 ± 0,03 0,79 ± 0,03 1,33 ± 0,05 
10 days 0,60 ± 0,05 0,94 ± 0,07 1,51 ± 0,12 
20 days 0,94 ± 0,02 1,14 ± 0,02 1,67 ± 0,06* 
Hepatopancreas 2,5 h 5 h 20 h 
4 days 1,14 ± 0,02 1,51 ± 0,02 2,04 ± 0,05* 
8 days 0,57 ± 0,03 0,88 ± 0,03 1,70 ± 0,46 
10 days 0,58 ± 0,01 0,87 ± 0,03 1,38 ± 0,06 
20 days 0,65 ± 0,04 0,97 ± 0,03 1,57 ± 0,04 
It is possible to see that the cells from the gills and hepatopancreas grew during the 
experiment. However, the growth rate was different for the different days of feeding. After 
20 h of exposure to Alamar Blue, in cells from the gills it was observed that the growth 
rate of 4 days of feeding and 20 days (depuration period) was significantly higher than the 
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growth rate of 8 and 10 days of feeding. With the cells from hepatopancreas it was 
observed that the growth rate of 4 days was significantly higher than the rest of the 
feeding period and depuration period. 
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4. Discussion 
4.1. Bioaccumulation experiment 
In literature, it was reported the presence of BMAA in several marine animals, 
showing that biomagnification of BMAA may occur across trophic chain (Brand et al., 
2010; Jonasson et al., 2010). 
Various studies with cyanotoxins have shown that bivalves are able to accumulate 
toxins (Vasconcelos, 1995; Karlsson et al., 2003; Pereira et al., 2004; Pires et al., 2004; 
Saker et al., 2004 and Osswald et al., 2008). Among these reports there is a common 
agreement that bivalves are quite resistant to toxins. Feeding responses to toxic cells are 
widely used as good indicators of toxin accumulation and sensitivity in bivalves (Pereira et 
al., 2004), 
In this work, accumulation of BMAA by mussels was shown. Mussels exposed to 
BMAA standard for 24 h and 48 h were able to uptake this amino acid, when provided with 
purposely higher concentrations. The results obtained showed that the mussels had 
higher uptake rate in the first 24 h and that rate decreased during the second 24 h of 
exposure.  
Likewise, mussels fed with cyanobacteria (S. salina) showed bioaccumulation of 
BMAA. The increase in the levels of BMAA during the feeding period was not constant, 
since the amount that was uptake in the first 4 days was higher than was uptake after 8 
and 10 days of feeding. After 10 days of depuration it was still possible to find levels of 
BMAA in the mussels, although these were significantly lower.  
Similar accumulation results were obtained in previous studies dealing with 
cyanotoxins and mollusks. For example, Amorim and Vasconcelos (1999) reported 
accumulation of PST by Anodonta cygnea and Saker et al. (2004) reported accumulation 
of cylindrospermopsin by A. cygnea.  
With anatoxin-a, a neurotoxin that has similar characteristics as BMAA (such as high 
level of solubility in water), no accumulation by M. galloprovincialis was observed 
(Osswald et al., 2008). Although this mussel was able to uptake anatoxin-a it did not 
accumulate it in very high rates and depurated it fast (Osswald et al., 2008). In this study it 
was observed an accumulation of BMAA. The fact that the mussel was able to accumulate 
38 
BMAA reinforces the idea that BMAA is predominantly bound to proteins, and not in the 
free form. This can help explain why BMAA, being soluble like anatoxin-a, can be 
accumulated by mussels.  
It is noteworthy that mussels collected at the beach and mussels that were fed with 
Chlorella sp., as a control, did not present detectable BMAA. Therefore, the levels of 
BMAA present in the mussel fed with cyanobacteria were considered due to the feeding. 
Interestingly, the cyanobacteria used to feed the mussels did not present detectable levels 
of BMAA. These results show that the mussel was able to concentrate BMAA to a level 
high enough to be measured, thus supporting the BMAA bioaccumulation hypothesis, 
through the trophic chain. 
The samples that were enzymatically digested showed similar results to the samples 
acid digested. As far as we know, enzymatic digestion has not yet been reported for 
BMAA extraction. This step was performed to simulate digestion processes in the 
stomach and small intestine of animals. In principle, in vitro digestion models provide a 
useful alternative to animal and human models by rapidly screening food ingredients (Hur 
et al., 2011). The enzymes used are known to be proteases and are present in the 
stomach (pepsin) and small intestine (trypsin/chymotrypsin). They are responsible for 
breaking down proteins/peptides into smaller peptides and amino acids (Hur et al., 2011).  
A decrease in the levels of BMAA during the depuration period could be explained by 
detoxification of BMAA by the mussel, mediated by these digestive enzymes.  Moreover, it 
can be hypothesized that similar BMAA releasing mechanisms will take place in 
organisms that feed on mussels. Since the enzymatic digestion allows the release of part 
of the total BMAA in the organism, it might also happen in the next trophic level. Amongst 
mussel predators are many marine organisms, such as fish or octopus, and also terrestrial 
organisms, such as humans. 
Unlike what had happen for the mussel, none of the analyzed sea snail samples was 
positive for BMAA. This may have happened because this animal does not uptake or 
accumulates BMAA. Sea snails are grazers, and moving organisms, and might not have 
eaten the cyanobacteria provided in the bioaccumulation experiment or the cyanobacteria 
ingestion might not have been enough to quantify BMAA in the organism. 
Another explanation can be the analytical method used. In this study two different 
methods were used, one using derivatization and another not using this step. The 
samples that were derivatized never allowed the quantification of BMAA.  
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Many discrepancies in published results on BMAA concentration can be seen in the 
literature (Banack et al., 2010a; Faassen et al., 2012; Glover et al., 2012). This may have 
happened because there is not a standard procedure to determine BMAA in various 
samples (e.g. cyanobacteria, marine invertebrates and vertebrates, etc.). Faassen et al. 
(2012) suggested that the differences in results may to be related to the analytical method 
used. It has been suggested that LC-MS/MS is a more selective and appropriate method 
for BMAA detection (Banack et al., 2010a; Faassen et al., 2012). Underivatized LC-
MS/MS analysis and derivatized LC-MS/MS analysis are the most common methods 
used. The derivatization step is used to react with primary and secondary amino groups 
and make the molecule easier to detect and distinguish from structurally similar 
compounds by increasing its molecular weight (Banack et al., 2010a). However, some 
authors defend that this derivatization step is not specific, i.e. the derivatizing agent can 
react with all amino acids and other amino group containing compounds (Faassen et al., 
2012). So there is always a chance that a derivatized compound other than BMAA has a 
similar retention time as the BMAA derivative (Faassen et al., 2012). In this study mussel 
samples were analyzed with both derivatization and without derivatization and sea snails 
samples were analyzed only with derivatization. Although the equipment used to analyze 
the derivatized samples is more sensitive than the one used to analyze the underivatized 
samples, no results were obtained with derivatized samples.  
It has been also suggested that matrix effects may be complicating factors in BMAA 
analysis (Glover et al., 2012). Since, BMAA is a highly reactive molecule, it has the 
potential to interact with other molecules during the analysis, which may interfere with the 
accurate quantification (Li et al., 2010; Glover et al., 2012). Once a complex matrix is 
present, more chemical interactions can occur interfering with the analysis (Li et al., 2010; 
Glover et al., 2012). The failure to detect BMAA cannot be considered an absence of the 
compound.  
4.2. Metabolic activity of cells of mussels fed with cyanobacteria 
In this study, the metabolic activity of cells from the mussels fed with cyanobacteria 
was reported. The cytotoxicity of BMAA in mussels has not yet been investigated. In this 
work, we tested the effect of this neurotoxin on mussel cells of the gills and 
hepatopancreas by using Alamar Blue.  
Given their feeding behavior, bivalves can accumulate molecules that are potentially 
dangerous for human health, including biotoxins (Louzao et al., 2010). However the 
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interaction of these toxins with the cells from bivalves can be very different. For example, 
palytoxin dramatically decreases the percentage of mantle and hepatopancreas cells 
(Louzao et al., 2010). Some toxins, like okadaic acid and azaspiracid-1 do not influence 
the viability of mussels cells (Louzao et al., 2010). 
As it was possible to see in this work, BMAA can be accumulated by mussels. For 
this reason, it is important to see if this neurotoxin can affect the cells of M. 
galloprovincialis. The results showed that in both groups of cells (gills and 
hepatopancreas) there was an increase of the inhibition of metabolic activity, as the 
feeding period increased. These results show that BMAA affects bivalve cells, even when 
no differences can be seen in the accumulation of this toxin, indicating that the 
harmlessness of BMAA for mussels might be only apparent. Such data could be important 
to evaluate the real ecological impact of the toxin and can contribute to clarify how toxic 
molecules such as BMAA can be in some bivalves without any apparent effects. 
It was also possible to see that, although the uptake rate of BMAA by mussels has a 
peak in the first 4 days, followed by a decrease, the growth rate of the cells from the gills 
and hepatopancreas of mussels fed during 8 and 10 days was lower than the cells from 4 
days of feeding. That difference was higher in cells from hepatopancreas. Furthermore, 
the growth rate during the depuration period was lower in cells from the hepatopancreas 
than the cells from the gills, meaning that the cells from hepatopancreas were more 
affected than the others. This was expected since the hepatopancreas is an organ of the 
digestive tract of mollusks that is responsible for the absorption of digested food. 
However, an important factor that has to be considered is the fact that the diet of the 
mussels is not mainly constituted by cyanobacteria. In fact, the most common food that is 
given to mussels that produces a higher growth rates and survival in aquaculture is mainly 
diatoms and flagellates (Davenport et al., 2000; Knauer and Southgate, 2007). So, partly 
the results obtained with the inhibition of the metabolic rate can be due to some stress as 
a response to the diet given, based only in cyanobacteria. 
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5. Conclusion 
BMAA is a neurotoxin produced by cyanobacteria found in aquatic and terrestrial 
ecosystems. The ubiquity of cyanobacteria, including BMAA-producing strains, and the 
link between this toxin and neurodegenerative diseases pose a threat to humans. Recent 
findings of BMAA in different aquatic organisms suggest the occurrence of 
bioaccumulation in trophic chains. 
With the mussels exposed to BMAA standard it was observed an accumulation of this 
neurotoxin and the uptake rate was higher at the first 24 h of exposure. For M. 
galloprovincialis fed with BMAA-producing cyanobacteria, an accumulation of BMAA was 
observed. With the enzymatic digestion of the mussels it was possible to see that BMAA 
might be transferred to the next trophic level, because these enzymes allowed the release 
of some BMAA from the organism. 
Regarding the experiment with G. umbilicalis, no BMAA accumulation was observed. 
Some reasons can be given for this result. One of them is the way that sea snails feed. 
Maybe, because they are grazers, not enough cyanobacteria was eaten and therefore not 
sufficient BMAA was accumulated to be detected. So, the way of feeding of organisms 
can influence the quantity of BMAA ingested by them. 
Two different methods were used in this study for BMAA analysis. Some samples 
were derivatized and the others were analyzed without derivatization. The samples that 
were derivatized never allowed the quantification of BMAA. Even though the equipment 
used for derivatized samples had a limit of detection lower than the equipment used for 
underivatized samples, it was not possible to detect BMAA in these samples. There are 
disagreements about which analytical method is better for BMAA detection. One of the 
complicating factors for this detection can be the matrix effect of biological samples. So, it 
is important to have a method that provides unambiguous identification and quantification 
of BMAA, since this neurotoxin has a link with neurodegenerative diseases. 
The metabolic activity of cells from the mussels fed with cyanobacteria showed that in 
both cells used (gills and hepatopancreas) there was an increase of the inhibition of 
metabolic activity as the feeding period increased. One of the reasons for these results 
can be the fact that BMAA can affect cells from mussels. Although accumulation was 
observed in mussels without any apparent harm, BMAA can perturb the normal function of 
the cells. Other possible explanation can be the diet given to these mussels, during the 
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experiment. Because cyanobacteria were used exclusively to feed these organisms, there 
may have been some stress response that affected the metabolic activity of the cells. 
Nevertheless, further investigation should be done to better understand the mechanism of 
action of BMAA in marine invertebrates.  
This study highlights the fact that there is a possible bioaccumulation of BMAA by M. 
galloprovincialis, an organism important in the aquatic ecosystem and present in the diet 
of many organisms, including humans. The fact that digestive enzymes allow the release 
of BMAA from mussels can foreseen a similar process into the organism that feed on 
them, enabling biomagnification of this neurotoxin through the trophic chain. 
Further investigation on bioaccumulation of BMAA in higher levels of the trophic chain 
is needed. Concerning BMAA analysis, more investigation should be done to develop a 
standard procedure to detect and quantify BMAA in various complex samples, so more 
confidence on the results can be obtained. 
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